Skip to content
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance
2 days ago
Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets
2 days ago
Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration
2 days ago
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%
2 days ago
Infographic: How Philip Morris (PM) performed in Q4 2025 financial results
2 days ago
Abbott reports positive results from study on its atrial fibrillation therapies
2 days ago
Atmus Welcomes Heath Sharp to Board of Directors
2 days ago
Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues
2 days ago
Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026
4 days ago
Yum China Reports Fourth Quarter and Full Year 2025 Financial Results
4 days ago
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance
2 days ago
Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets
2 days ago
Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration
2 days ago
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%
2 days ago
Infographic: How Philip Morris (PM) performed in Q4 2025 financial results
2 days ago
Abbott reports positive results from study on its atrial fibrillation therapies
2 days ago
Atmus Welcomes Heath Sharp to Board of Directors
2 days ago
Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues
2 days ago
Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026
4 days ago
Yum China Reports Fourth Quarter and Full Year 2025 Financial Results
4 days ago
Strengths
- NIM Expansion: Sequential improvement in net interest margin to 2.68% indicates effective deposit pricing.
- Core Profitability: 128.6% year-over-year increase in core EPS demonstrates operational recovery.
- Capital Position: Tangible common equity ratio improved to 8.14%, up 32 basis points from the prior year.
Weaknesses
- CRE Concentration: High exposure to New York real estate at 465% of total capital remains a regulatory focal point.
- Missed Estimates: Q4 revenue and core EPS fell slightly below consensus analyst expectations.
- GAAP Volatility: Sensitivity to fair value adjustments led to a wide gap between GAAP ($0.12) and Core ($0.32) EPS.
Opportunities
- Transformational Merger: Combination with OceanFirst provides greater scale and a $225 million equity infusion.
- Deposit Mix: 12% growth in noninterest-bearing deposits reduces the overall cost of funds.
- Liquidity: Strong liquidity position with $3.9 billion in available funds as of year-end 2025.
Threats
- Real Estate Macro: Continued pressure on office and multi-family valuations in the New York market.
- Regulatory Hurdles: Pending merger completion is subject to standard regulatory approvals and closing conditions.
- Trade Policy: Indirect impact of tariffs on the local commercial and industrial (C&I) borrower base.